COYA COYA
Company Profile ↓Company Overview
COYA (COYA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $7.95M (+123.6% YoY); net profit $-21.23M.
- Trailing 12 Months Year-on-year growth — revenue +123.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 123.57% |
Stock Price Performance
| 1 Year: | -28.23% |
| 6 Months: | -6.38% |
| 3 Months: | +7.06% |
| 1 Month: | -20.87% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)48.62 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 38.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 0 | 0 | 0 | 126.84K | 3.43M | 0 | 257.88K | 163.62K | 3.56M | 251.15K |
| Operating Income | -1.70M | -3.45M | -2.66M | -2.90M | -3.25M | -3.56M | -5.48M | -3.24M | -4.45M | -7.68M | -6.41M | -2.43M | -7.64M |
| Net Income | -1.70M | -3.41M | -4.02M | -2.74M | -3.10M | -3.42M | -5.05M | -2.89M | -4.02M | -7.31M | -6.09M | -2.12M | -7.21M |
| Diluted EPS | -0.66 | -1.32 | -1.55 | -0.28 | -0.31 | -0.34 | -0.35 | -0.19 | -0.26 | -0.44 | -0.36 | -0.13 | -0.32 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 6.00M | 3.55M | 7.95M |
| Operating Income | -4.87M | -9.81M | -7.90M | -17.25M | -22.56M |
| Net Income | -4.89M | -12.24M | -7.99M | -14.88M | -21.23M |
| Diluted EPS | -1.89 | -4.73 | -0.79 | -0.98 | -1.27 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 4.79M | 8.40M | 41.26M | 44.35M | 49.95M |
| Total Equity | 8.30M | 3.64M | -8.39M | 35.64M | 39.58M | 43.03M |
| Cash & Equivalents | - | 4.34M | 5.93M | 32.63M | 38.34M | 46.82M |
| Total Liabilities | - | 1.15M | 16.79M | 5.63M | 4.77M | 6.92M |
| Current Liabilities | - | 1.15M | 3.82M | 5.05M | 3.82M | 5.87M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -3.90M | -7.24M | -11.19M | -10.29M | -10.74M |
| Investing Cash Flow | -136.80K | -525.00K | -543.19K | -25.00K | -1.16M |
| Financing Cash Flow | -340.58K | 9.36M | 38.43M | 16.03M | 20.39M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | -131.7% | -485.4% | -283.9% |
| Net Margin % | - | - | -133.1% | -418.7% | -267.1% |
| ROE % | -134.3% | 145.9% | -22.4% | -37.6% | -49.3% |
| ROCE % | -133.7% | -214.6% | -21.8% | -42.6% | -51.2% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for COYA
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQM1RkWkh2WTB4UGE5YWgzT1NuZDNWN2Q4aDRQNEZJQ1A5MXhzdkRIRG5jcmRxT25ERGt2MnRsOWRHbklIRFlOd0hkRTB5Mi1ncG5GYUVZM2hTNXc2M0RkZWIyNkhFOHA1T0ljREdEMTc1Q3gwSC1VaElhNUlUWlVwUEJFclRQaUpLN242dk…
Avoiding Lag: Real-Time Signals in (COYA) Movement - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOcFRwYnZqNFZHZGVKV092YTdtSmhwUURNWnVkb2h2elJFS3pYYmN0eEVSQldqZElYR1FKdDNyYTVqQWRpcDNlcHhySlVzNmdfWHdoQjJIRVlaZkVLVkRYdXFKa1Z1WHFRLUpab204djRZM2xCSEVjbDJkTzRvdFk2WjhxRF9xNkVNelNxYl…
Coya Therapeutics (NASDAQ: COYA) holder discloses 3.3% stake in amended filing - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQVWpXZXJKTF80T05iRDd2RHA2aHdxaVdfdmI5T3d0MkFSR1QwSkJQTG1ZYVlGRElTellXOEFpb092Z2xOQ0VCcmF5TW1rY0FUTFp4bFk4bFRkZ25qTGFmWHVxMFQwbEFYTktMYmFjWHY4em1VWGVpS1dseVltLXpSWFlhdnhwQnhiT3dRcH…
COYA Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1TTUczY3dqeENkN05RVERsUzRPdTVjNjNZZFA3X24zVjhKUkxoQ3prcXZLYU81YlhUVGdxY0JLTF9POGF5cWJCR3huODh3S0NYcGF0V2Z0ZURmNDZyOHFuNkFvYWV3aGNfcjhIakJrQUYwdi0zQ25HTW1B?oc=5" target="_blank">COY…
COYA|Coya Therapeutics Inc|Price:4.440|Chg%:+0.250 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5tTHI5NjJIaHVSWm9ILXVHQnY5dlZTS25YS3luVlVPaml0Nnd2Qld6dnl2cW9rRmVrWmNJa3hTVVdrbURwNUU2TV9aQmxURnZpaVFQTFJXRTRBdE1ETTVnT0pRam12amtZcnB1a09R?oc=5" target="_blank">COYA|Coya Therapeut…
Coya Targets ALS Trial Readout in Q1 2027, H.C. Wainwright Sets US$18 Price Target - Streetwise Reports
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPZ3JMX2pKWW1PampDb0dObEtnaWl5MFk4WlpHTDQ0WkVEcThpU0tYaVNzZVBnd1BGVHFrMGw4VDNYQ1cySlFwaU9qazBWS1U0ZkwwQWs2WG5ZaDhsY1hOYXZ6UnhTdkoybFF3clJZbHhUSkpXUWFlMG4xWkM5ZHZaYm8zSHNPbjlPRlJnTT…
COYA — Frequently Asked Questions
What is the current share price of COYA?
As of 2026-08-05 17:25 PDT, COYA trades at $4.55 on NASDAQ/NYSE. Its 52-week range is $3.78 to $7.36.
What is the P/E ratio of COYA?
COYA trades at a trailing price-to-earnings (P/E) ratio of -3.58.
What is the return on equity (ROE) of COYA?
COYA has a return on equity (ROE) of -49.33%. Its return on capital employed (ROCE) is -51.17%.
Is COYA a good stock to buy?
This page provides a data-driven analysis of COYA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.